NIH-funded research R03 grant

How B cells can help protect lungs from damage caused by too much oxygen

Official title: Protective role of B cells in hyperoxic lung injury

Funded at Massachusetts General Hospital · NIH-10984706 · Data updated 2026-11-12

This study is looking at how certain immune cells called B cells can help protect the lungs from damage caused by high oxygen levels, which are often used to treat seriously ill patients with breathing problems, and it hopes to find ways to improve lung health for those patients.

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startAugust 1, 2024
Project endJuly 31, 2026
Funding year2024
Award (this year)$124,536
NIH project number1R03HL171347-01A1
Project IDNIH-10984706 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are critically ill patients with acute respiratory distress syndrome or similar lung injuries requiring oxygen therapy.

Less likely to help

Patients who do not have lung injuries or those not requiring oxygen therapy may not benefit from this research.

What this research studies

This research investigates the role of B cells in protecting the lungs from injury caused by high levels of oxygen, which are often necessary for treating critically ill patients with conditions like acute respiratory distress syndrome (ARDS). The study uses animal models to explore how hyperoxia can lead to inflammation and lung damage, particularly focusing on the depletion of B cells. By administering naïve B cells during hyperoxic exposure, the researchers aim to determine if this can reduce inflammation and improve lung function. The findings could lead to new therapeutic strategies for patients suffering from lung injuries.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that help protect lung function in patients receiving high levels of oxygen.

How similar studies have gone: Previous research has shown that B cell therapies can be beneficial in other inflammatory conditions, suggesting potential success for this novel approach.

Where this research is happening

  • Massachusetts General Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Hanidziar, Dusan — Massachusetts General Hospital
  • Study coordinator: Hanidziar, Dusan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.